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Background
Cardiac Amyloidosis (CA) is an important prognostic indi-
cator in patients with systemic amyloidosis. Cardiac MRI
has emerged as imaging modality of choice to evaluate
patients with CA. Delayed hyper-enhancement cardiac
magnetic resonance (DHE-CMR) provides incremental
diagnostic and prognostic utility in suspected CA. We per-
formed a meta-analysis to evaluate the prognostic role of
LGE by CMR (LGE-CMR) imaging in patients with CA.
Methods
Electronic databases MEDLINE, PubMed, Embase and
Cochrane were systematically searched to identify studies
evaluating the association between LGE-CMR and CA.
The present study was designed to systematically review
and assess the association between LGE and CA. The pri-
mary end-point was all-cause mortality. Pooling of odds
ratios (OR) was performed using a random-effect model.
Data were included from 7 studies with a total of 503
patients and a mean follow-up of 26 months.
Results
Patients had a weighted average age of 62 years, LVEF of
57.6% and 62% were male. Cardiac Biopsy was positive
for 21% patients while rest had evidence of positive extra
cardiac biopsy, clinical and/or imaging features consis-
tent for CA. LGE was present in 46% of patients.
LGE positive patients had increased overall mortality
1Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Full list of author information is available at the end of the article
Figure 1
Raina et al. Journal of Cardiovascular Magnetic
Resonance 2016, 18(Suppl 1):P115
http://www.jcmr-online.com/content/18/S1/P115
© 2016 Raina et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
compared to those without LGE (pooled OR 4.29, 95% CI
1.70 to 10.82, p = 0.002).
Conclusions
LGE in CA patients is associated with increased risk of
all-cause mortality; thus detection of LGE by CMR has
prognostic implications which can provide risk stratifica-
tion and further management in patients with CA.
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